4-hydroxy-3-iodo-5-nitrophenylacetic acid (NIP)

4-hydroxy-3-iodo-5-nitrophenylacetic acid, commonly known as NIP, is a synthetic small molecule that serves as a classic model hapten in the field of immunology [1, 3]. It is a derivative of the 4-hydroxy-3-nitrophenylacetyl (NP) hapten, distinguished by the presence of an iodine atom at the 3-position of the phenol ring [7, 14]. NIP is not naturally occurring and is primarily used in research to study the mechanisms of the humoral immune response, including B-cell activation, affinity maturation, and the 'carrier effect' when conjugated to immunogenic proteins [7, 13]. Because certain anti-NP antibodies exhibit 'heteroclitic' binding—meaning they bind NIP with higher affinity than the original NP immunogen—NIP has been a vital tool for investigating antibody specificity and the structural basis of antigen recognition [8, 9]. In modern biotechnology, NIP is often employed as a specific ligand for engineered receptors, such as in the development of universal chimeric antigen receptor (CAR) T-cell systems, where it acts as a bridge between the CAR-T cell and a tumor-targeting module [4, 5]. Despite its utility in experimental settings and diagnostic assays, NIP is not a therapeutic target for any disease and does not possess intrinsic pharmacological activity [6, 17]. It is frequently used as a negative control in immunological assays due to its well-characterized interaction with specific monoclonal antibodies like B1-8 [4, 16]. The molecule's ability to be easily synthesized and conjugated to various carriers makes it an ideal tool for probing the limits of immune recognition and tolerance [6, 11].

Other names

3-iodo-4-hydroxy-5-nitrophenylacetic acidNIP hapten(4-hydroxy-3-iodo-5-nitrophenyl)acetic acid4-hydroxy-3-iodo-5-nitro-phenylacetic acid